INSIGHTS ON CLINICAL TRIAL PARTNERING
-
ESMO Congress 2025: Highlights From Berlin
Turn the insights from this year’s ESMO into action by partnering to accelerate innovation through smarter trial design, stronger biomarker planning, and truly global collaboration.
-
Community-Focused Site Networks Increase Access And Trial Reach
Community-based site networks enhance clinical trial equity by engaging diverse populations, improving enrollment, retention, and developing therapies effective across varied patient groups.
-
Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO
In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.
-
The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials
Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.
-
Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies3/24/2025
To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.
-
Why Functional Outsourcing Is Important To Clinical Development8/1/2025
Craig McIlloney, Senior Vice President of Catalyst Flex, discusses why functional outsourcing is important in today's clinical development environment, how Catalyst Flex supports this, and is scalable to flex to your changing needs.
-
Stipends Create More Tax Burden — Here's A Better Option7/22/2025
Explore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026.
-
Why The Regional Site Manager Is The Swiss Army Knife Of Clinical Trial Monitoring1/28/2025
The Regional Site Manager (RSM) monitoring model eliminates numerous clinical trial risks by leveraging efficient, start-to-finish site management by a single, expert point of contact.
-
Expert Consulting And MRCT Strategy Rescues Oncology Program1/3/2024
Uncover how this strategic approach yielded significant outcomes, including uncovering missing data through IB review, streamlining dosing timelines, and achieving successful recruitment milestones.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Our Approach
At Southern Star Research, we have extensive experience across all aspects of clinical operations and a wide range of therapeutic areas. We specialize in providing flexible, high-quality, and custom solutions that help you deliver regulator-ready data on time and at a predictable price.
As a large proportion of our clients are geographically dispersed, we understand how important it is to be able to trust that your CRO is working in your best interests. That’s why we pride ourselves on building strong, transparent, and close relationships with our clients.
Our team of experts will guide you through the clinical trial process using a proactive and collaborative approach, ensuring that your stakeholders are always informed, in control, and confident throughout the journey.
-
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.
-
With the right Chemistry, Manufacturing & Controls (CMC) consulting services, your organization can excel in early-stage strategizing, accelerate timelines, optimize processes, and reduce costs.
-
For clinical trial technology vendors, it’s fast and easy to become part of the only industry-wide solution to sit tech overload.
-
Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.